The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
CompletedNCT01688583
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to assess the effectiveness and tolerability of Fentanyl matrix in chronic non-cancer pain.
Study details
- Official title
- The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement: Multicenter, Prospective, Open-label, Observational Study
- Conditions
- Interventions
- Drug: Fentanyl matrix
- Sponsor
- Janssen Korea, Ltd., Korea
- Start date
- 2011-12
- Primary completion
- 2013-03
- Sex
- All
- Age range
- from 20 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 11
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Complain of chronic non-cancer pain that persists for \>= 3 months * Pain inadequately controlled by previous treatment with narcotic analgesics (opium or opium-like compounds with potent analgesic effects, eg, tramadol, codeine, morphine, oxycodone) * Women must be postmenopausal, surgically sterile, abstinent, or practicing an effective method of birth control if they have childbearing potential * Male patients who agree to use a method of birth control and not to donate sperm for 1 month after the last dose of the study drug * A written informed consent for study participation Exclusion Criteria: * Experience of treatment with Fentanyl matrix within the past 4 weeks * No previous experience of use of narcotic analgesics * Past or current history of alcohol or drug abuse * Cannot use transdermal analgesics due to skin disorder * Have serious psychiatric disorder and cannot complete overall study procedures and questionnaire in the judgment of the investigator
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01688583